Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov;79(11):1579-1581.
doi: 10.1007/s00228-023-03564-7. Epub 2023 Sep 19.

Missing PPI prescriptions while overprescribing?

Ingrid Schubert  1 , Veronika Lappe  2 , Ursula Marschall  3 , Daniel Grandt  4
Affiliations
Comment

Missing PPI prescriptions while overprescribing?

Ingrid Schubert et al. Eur J Clin Pharmacol. 2023 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1
Fig. 1
Percentage of the study population without PPI by insured persons with NSAID and simultaneous use of i) anticoagulants/antithrombotic agents or ii) glucocorticoids. i) Men (n = 35,395); women (n = 47,361); total (n = 82,756). ii) Men, 13,336; women, 27,983; total, 41,319. Data: scientific data warehouse BARMER; study population: insured persons > 17 years of age without a diagnosis of malignant neoplasm; simultaneous use over 28 days
See this image and copyright information in PMC

Comment on

References

    1. Shanika LGT, Reynolds A, Pattison S, Braund R (2023) Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol 79(9):1159–1172. 10.1007/s00228-023-03534-z - PMC - PubMed
    1. Rückert-Eheberg I-M, Nolde M, Ahn N, Tauscher M, Gerlach R, Güntner F, Günter A, Meisinger C, Linseisen J, Amann U et al (2022) Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018. Eur J Clin Pharmacol 78(4):657–667. 10.1007/s00228-021-03257-z - PMC - PubMed
    1. Lappe V, Dinh TS, Harder S, Brueckle M-S, Fessler J, Marschall U, Muth C, Schubert I, and on behalf of the EVITA Study Group Multimedication guidelines: assessment of the size of the target group for medication review and description of the frequency of their potential drug safety problems with routine data. Pharmacoepidemiology. 2022;1(1):12–25. doi: 10.3390/pharma1010002. - DOI
    1. Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G et al (2014) Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology 147(4):784–792.e789; quiz e713–784. 10.1053/j.gastro.2014.06.007 - PubMed
    1. Grandt D, Gamstätter T (2021) S2k-Leitlinie Arzneimitteltherapie bei Multimorbidität – living guideline. https://register.awmf.org/assets/guidelines/100-001l_S2k_Arzneimittelthe.... Accessed 27 Aug 2023

Substances

LinkOut - more resources